Company Filing History:
Years Active: 2013
Title: Liane Klingensmith: Innovator in Pharmaceutical Chemistry
Introduction
Liane Klingensmith is a notable inventor based in Stoughton, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit specific enzymes related to various health conditions.
Latest Patents
Liane holds a patent for a process related to making substituted 2-amino-thiazolones. This invention focuses on methods for creating compounds that inhibit the 11-β-hydroxysteroid dehydrogenase type 1 enzyme (11-β HSD1). The patented process involves several steps, including contacting a compound with a chiral base and an alkylating agent, followed by the formation of a salt and subsequent reactions to yield the final compound.
Career Highlights
Liane Klingensmith is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to engage in innovative research and development, contributing to advancements in therapeutic solutions.
Collaborations
Throughout her career, Liane has collaborated with esteemed colleagues, including George Moniz and Matthew J Frizzle. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Liane Klingensmith's contributions to pharmaceutical chemistry and her innovative patent demonstrate her commitment to advancing medical science. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.